Effects of CD4<sup>+</sup> T&nbsp;lymphocytes from ovariectomized mice on bone marrow mesenchymal stem cell proliferation and osteogenic differentiation

Shao,Bing-Yi; Wang,Lan; Yu,Yang; Chen,Liang; Gan,Ning; Huang,Wen-Ming

doi:10.3892/etm.2020.9212

November-2020 Volume 20 Issue 5

Full Size Image

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

An International Open Access Journal Devoted to General Medicine.

November-2020 Volume 20 Issue 5

Full Size Image

Article Open Access

Effects of CD4⁺ T lymphocytes from ovariectomized mice on bone marrow mesenchymal stem cell proliferation and osteogenic differentiation

Authors:
- Bing-Yi Shao
- Lan Wang
- Yang Yu
- Liang Chen
- Ning Gan
- Wen-Ming Huang
View Affiliations / Copyright

Affiliations: Department of Operative Dentistry and Endodontics, Stomatological Hospital of Chongqing Medical University, Chongqing 400047, P.R. China

Copyright: © Shao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
Article Number: 84
|
Published online on: September 11, 2020

https://doi.org/10.3892/etm.2020.9212
Expand metrics +

Abstract

The present study was designed to investigate the effects of T cells on the proliferation and osteogenic differentiation of bone marrow mesenchymal stem cells (BMMSCs). BMMSCs were co‑cultured with CD4⁺ T cells that had been pretreated with anti‑TNF‑α or controls and were derived from ovariectomized (OVX) mice or sham control mice. MTT was used to assess the proliferative ability of BMMSCs and flow cytometry was used to analyze the BMMSC cell cycle. Following the induction of osteogenic differentiation in BMMSCs, calcium nodules were observed using alizarin red staining and alkaline phosphatase (ALP) staining. The expression levels of the osteogenesis‑associated genes, runt related transcription factor 2 (Runx2) and osteocalcin (OCN) in BMMSCs were quantified using reverse transcription‑quantitative PCR and western blotting. Osteogenesis‑related signaling pathways, including ERK, JNK and p38 MAPK were also examined by western blotting. BMMSCs co‑cultured with CD4⁺ T cells from OVX mice exhibited reduced proliferative ability compared with sham mice and the cell cycle was arrested at the G2/M phase. Additionally, BMMSCs co‑cultured with CD4⁺ T cells from OVX mice presented with reduced levels of osteogenic differentiation and lower ALP activity, less calcium deposition and reduced expression of Runx2 and OCN compared with sham mice. The reduced levels of proliferation and osteogenic differentiation of BMMSCs induced by CD4⁺ T cells were not seen when the T cells were had been pretreated with anti‑TNF‑α. The results indicated that CD4⁺ T cells from OVX mice inhibited the proliferation and osteogenic differentiation of BMMSCs by producing high levels of TNF‑α and may provide a novel insight into the dysfunction of BMMSCs caused by estrogen deficiency.

View Figures

View References

1	Lane JM, Russell L and Khan SN: Osteoporosis. Clin Orthop Relat Res 139-150, 2000.
2	McCormick RK: Osteoporosis: Integrating biomarkers and other diagnostic correlates into the management of bone fragility. Altern Med Rev. 12:113–145. 2007.PubMed/NCBI
3	De Martinis M, Sirufo MM and Ginaldi L: Osteoporosis: Current and emerging therapies targeted to immunological checkpoints. Curr Med Chem: Jul 30, 2019 (Epub ahead of print). doi: 10.2174/0929867326666190730113123.
4	Aggarwal BB, Shishodia S, Takada Y, Banerjee S, Newman RA, Bueso-Ramos CE and Price JE: Curcumin suppresses the paclitaxel-induced nuclear factor-kappaB pathway in breast cancer cells and inhibits lung metastasis of human breast cancer in nude mice. Clin Cancer Res. 11:7490–7498. 2005.PubMed/NCBI View Article : Google Scholar
5	Datta HK, Ng WF, Walker JA, Tuck SP and Varanasi SS: The cell biology of bone metabolism. J Clin Pathol. 61:577–587. 2008.PubMed/NCBI View Article : Google Scholar
6	Khosla S, Oursler MJ and Monroe DG: Estrogen and the skeleton. Trends Endocrinol Metab. 23:576–581. 2012.PubMed/NCBI View Article : Google Scholar
7	Adori M, Kiss E, Barad Z, Barabás K, Kiszely E, Schneider A, Kövesdi D, Sziksz E, Abrahám IM, Matkó J and Sármay G: Estrogen augments the T cell-dependent but not the T-independent immune response. Cell Mol Life Sci. 67:1661–1674. 2010.PubMed/NCBI View Article : Google Scholar
8	Zhang N, Gui Y, Qiu X, Tang W, Li L, Gober HJ, Li D and Wang L: DHEA prevents bone loss by suppressing the expansion of CD4(+) T cells and TNFa production in the OVX-mouse model for postmenopausal osteoporosis. Biosci Trends. 10:277–287. 2016.PubMed/NCBI View Article : Google Scholar
9	Faienza MF, Ventura A, Marzano F and Cavallo L: Postmenopausal osteoporosis: The role of immune system cells. Clin Dev Immunol. 2013(575936)2013.PubMed/NCBI View Article : Google Scholar
10	Eastell R, O'Neill TW, Hofbauer LC, Langdahl B, Reid IR, Gold DT and Cummings SR: Postmenopausal osteoporosis. Nat Rev Dis Primers. 2(16069)2016.PubMed/NCBI View Article : Google Scholar
11	Li JY, Tawfeek H, Bedi B, Yang X, Adams J, Gao KY, Zayzafoon M, Weitzmann MN and Pacifici R: Ovariectomy disregulates osteoblast and osteoclast formation through the T-cell receptor CD40 ligand. Proc Natl Acad Sci USA. 108:768–773. 2011.PubMed/NCBI View Article : Google Scholar
12	Song H, Li X, Zhao Z, Qian J, Wang Y, Cui J, Weng W, Cao L, Chen X, Hu Y and Su J: Reversal of osteoporotic activity by endothelial cell-secreted bone targeting and biocompatible exosomes. Nano Lett. 19:3040–3048. 2019.PubMed/NCBI View Article : Google Scholar
13	Chen X, Zhi X, Wang J and Su J: RANKL signaling in bone marrow mesenchymal stem cells negatively regulates osteoblastic bone formation. Bone Res. 6(34)2018.PubMed/NCBI View Article : Google Scholar
14	Uehara IA, Soldi LR and Silva MJB: Current perspectives of osteoclastogenesis through estrogen modulated immune cell cytokines. Life Sci. 256(117921)2020.PubMed/NCBI View Article : Google Scholar
15	Sang C, Zhang J, Zhang Y, Chen F, Cao X and Guo L: TNF-α promotes osteoclastogenesis through JNK signaling-dependent induction of Semaphorin3D expression in estrogen-deficiency induced osteoporosis. J Cell Physiol. 232:3396–3408. 2017.PubMed/NCBI View Article : Google Scholar
16	Roggia C, Gao Y, Cenci S, Weitzmann MN, Toraldo G, Isaia G and Pacifici R: Up-regulation of TNF-producing T cells in the bone marrow: A key mechanism by which estrogen deficiency induces bone loss in vivo. Proc Natl Acad Sci USA. 98:13960–13965. 2001.PubMed/NCBI View Article : Google Scholar
17	Li J, Wang Q, Yang R, Zhang J, Li X, Zhou X and Miao D: BMI-1 mediates estrogen-deficiency-induced bone loss by inhibiting reactive oxygen species accumulation and T cell activation. J Bone Miner Res. 32:962–973. 2017.PubMed/NCBI View Article : Google Scholar
18	Bi H, Ming L, Cheng R, Luo H, Zhang Y and Jin Y: Liver extracellular matrix promotes BM-MSCs hepatic differentiation and reversal of liver fibrosis through activation of integrin pathway. J Tissue Eng Regen Med. 11:2685–2698. 2017.PubMed/NCBI View Article : Google Scholar
19	Phinney DG: Biochemical heterogeneity of mesenchymal stem cell populations: Clues to their therapeutic efficacy. Cell Cycle. 6:2884–2889. 2007.PubMed/NCBI View Article : Google Scholar
20	Bi H and Jin Y: Current progress of skin tissue engineering: Seed cells, bioscaffolds, and construction strategies. Burns Trauma. 1:63–72. 2013.PubMed/NCBI View Article : Google Scholar
21	Kim KI, Park S and Im GI: Osteogenic differentiation and angiogenesis with cocultured adipose-derived stromal cells and bone marrow stromal cells. Biomaterials. 35:4792–4804. 2014.PubMed/NCBI View Article : Google Scholar
22	Pilz GA, Ulrich C, Ruh M, Abele H, Schäfer R, Kluba T, Bühring HJ, Rolauffs B and Aicher WK: Human term placenta-derived mesenchymal stromal cells are less prone to osteogenic differentiation than bone marrow-derived mesenchymal stromal cells. Stem Cells Dev. 20:635–646. 2011.PubMed/NCBI View Article : Google Scholar
23	Gimble JM and Nuttall ME: The relationship between adipose tissue and bone metabolism. Clin Biochem. 45:874–879. 2012.PubMed/NCBI View Article : Google Scholar
24	Singh A, Mehdi AA, Srivastava RN and Verma NS: Immunoregulation of bone remodelling. Int J Crit Illn Inj Sci. 2:75–81. 2012.PubMed/NCBI View Article : Google Scholar
25	Liu Y, Wang L, Kikuiri T, Akiyama K, Chen C, Xu X, Yang R, Chen W, Wang S and Shi S: Mesenchymal stem cell-based tissue regeneration is governed by recipient T lymphocytes via IFN-γ and TNF-α. Nat Med. 17:1594–1601. 2011.PubMed/NCBI View Article : Google Scholar
26	Martinet L, Fleury-Cappellesso S, Gadelorge M, Dietrich G, Bourin P, Fournié JJ and Poupot R: A regulatory cross-talk between Vgamma9Vdelta2 T lymphocytes and mesenchymal stem cells. Eur J Immunol. 39:752–762. 2009.PubMed/NCBI View Article : Google Scholar
27	Biver G, Wang N, Gartland A, Orriss I, Arnett TR, Boeynaems JM and Robaye B: Role of the P2Y13 receptor in the differentiation of bone marrow stromal cells into osteoblasts and adipocytes. Stem Cells. 31:2747–2758. 2013.PubMed/NCBI View Article : Google Scholar
28	Yamaza T, Miura Y, Bi Y, Liu Y, Akiyama K, Sonoyama W, Patel V, Gutkind S, Young M, Gronthos S, et al: Pharmacologic stem cell based intervention as a new approach to osteoporosis treatment in rodents. PLoS One. 3(e2615)2008.PubMed/NCBI View Article : Google Scholar
29	Eljaafari A, Tartelin ML, Aissaoui H, Chevrel G, Osta B, Lavocat F and Miossec P: Bone marrow-derived and synovium-derived mesenchymal cells promote Th17 cell expansion and activation through caspase 1 activation: Contribution to the chronicity of rheumatoid arthritis. Arthritis Rheum. 64:2147–2157. 2012.PubMed/NCBI View Article : Google Scholar
30	Duffy MM, Pindjakova J, Hanley SA, McCarthy C, Weidhofer GA, Sweeney EM, English K, Shaw G, Murphy JM, Barry FP, et al: Mesenchymal stem cell inhibition of T-helper 17 cell-differentiation is triggered by cell-cell contact and mediated by prostaglandin E2 via the EP4 receptor. Eur J Immunol. 41:2840–2851. 2011.PubMed/NCBI View Article : Google Scholar
31	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
32	Duan L, Zhao H, Xiong Y, Tang X, Yang Y, Hu Z, Li C, Chen S and Yu X: miR-16-2^* Interferes with WNT5A to Regulate Osteogenesis of Mesenchymal Stem Cells. Cell Physiol Biochem. 51:1087–1102. 2018.PubMed/NCBI View Article : Google Scholar
33	Kelleher FC and O'Sullivan H: Monocytes, macrophages, and osteoclasts in osteosarcoma. J Adolesc Young Adult Oncol. 6:396–405. 2017.PubMed/NCBI View Article : Google Scholar
34	Kang SK, Shin IS, Ko MS, Jo JY and Ra JC: Journey of mesenchymal stem cells for homing: Strategies to enhance efficacy and safety of stem cell therapy. Stem Cells Int. 2012(342968)2012.PubMed/NCBI View Article : Google Scholar
35	D'Amelio P, Grimaldi A, Di Bella S, Brianza SZM, Cristofaro MA, Tamone C, Giribaldi G, Ulliers D, Pescarmona GP and Isaia G: Estrogen deficiency increases osteoclastogenesis up-regulating T cells activity: A key mechanism in osteoporosis. Bone. 43:92–100. 2008.PubMed/NCBI View Article : Google Scholar
36	Zhang JL, Qiu XM, Zhang N, Tang W, Gober HJ, Li DJ and Wang L: BuShenNingXin decoction suppresses osteoclastogenesis by modulating RANKL/OPG imbalance in the CD4⁺ T lymphocytes of ovariectomized mice. Int J Mol Med. 42:299–308. 2018.PubMed/NCBI View Article : Google Scholar
37	Aoki K, Saito H, Itzstein C, Ishiguro M, Shibata T, Blanque R, Mian AH, Takahashi M, Suzuki Y, Yoshimatsu M, et al: A TNF receptor loop peptide mimic blocks RANK ligand-induced signaling, bone resorption, and bone loss. J Clin Invest. 116:1525–1534. 2006.PubMed/NCBI View Article : Google Scholar
38	Kudo O, Fujikawa Y, Itonaga I, Sabokbar A, Torisu T and Athanasou NA: Proinflammatory cytokine (TNFalpha/IL-1alpha) induction of human osteoclast formation. J Pathol. 198:220–227. 2002.PubMed/NCBI View Article : Google Scholar
39	Algate K, Haynes DR, Bartold PM, Crotti TN and Cantley MD: The effects of tumour necrosis factor-α on bone cells involved in periodontal alveolar bone loss; osteoclasts, osteoblasts and osteocytes. J Periodont Res. 51:549–566. 2016.PubMed/NCBI View Article : Google Scholar
40	Marahleh A, Kitaura H, Ohori F, Kishikawa A, Ogawa S, Shen WR, Qi J, Noguchi T, Nara Y and Mizoguchi I: TNF-α Directly Enhances Osteocyte RANKL Expression and Promotes Osteoclast Formation. Front Immunol. 10(2925)2019.PubMed/NCBI View Article : Google Scholar
41	Du D, Zhou Z, Zhu L, Hu X, Lu J, Shi C, Chen F and Chen A: TNF-α suppresses osteogenic differentiation of MSCs by accelerating P2Y2 receptor in estrogen-deficiency induced osteoporosis. Bone. 117:161–170. 2018.PubMed/NCBI View Article : Google Scholar
42	Kumar G and Roger PM: From Crosstalk between Immune and Bone Cells to Bone Erosion in Infection. Int J Mol Sci. 20(5154)2019.PubMed/NCBI View Article : Google Scholar
43	Lecarpentier Y, Schussler O, Sakic A, Rincon-Garriz JM, Soulie P, Bochaton-Piallat ML and Kindler V: Human bone marrow contains mesenchymal stromal stem cells that differentiate in vitro into contractile myofibroblasts controlling t lymphocyte proliferation. Stem Cells Int. 2018(6134787)2018.PubMed/NCBI View Article : Google Scholar
44	Lu X, Wang X, Nian H, Yang D and Wei R: Mesenchymal stem cells for treating autoimmune dacryoadenitis. Stem Cell Res Ther. 8(126)2017.PubMed/NCBI View Article : Google Scholar
45	Rios C, Garbayo E, Gomez LA, Curtis K, D'Ippolito G and Schiller PC: Stem cells and their contribution to tissue repair. Stem Cell Regenerative Medicine. 1:9–22. 2010.
46	Sun Y, Liu WZ, Liu T, Feng X, Yang N and Zhou HF: Signaling pathway of MAPK/ERK in cell proliferation, differentiation, migration, senescence and apoptosis. J Recept Signal Transduct Re. 35:600–604. 2015.PubMed/NCBI View Article : Google Scholar
47	Cai TY, Zhu W, Chen XS, Zhou SY, Jia LS and Sun YQ: Fibroblast growth factor 2 induces mesenchymal stem cells to differentiate into tenocytes through the MAPK pathway. Mol Med Rep. 8:1323–1328. 2013.PubMed/NCBI View Article : Google Scholar
48	Hwang JH, Byun MR, Kim AR, Kim KM, Cho HJ, Lee YH, Kim J, Jeong MG, Hwang ES and Hong JH: Extracellular Matrix Stiffness Regulates Osteogenic Differentiation through MAPK Activation. PLoS One. 10(e0135519)2015.PubMed/NCBI View Article : Google Scholar
49	Huang RL, Yuan Y, Tu J, Zou GM and Li Q: Opposing TNF-α/IL-1β- and BMP-2-activated MAPK signaling pathways converge on Runx2 to regulate BMP-2-induced osteoblastic differentiation. Cell Death Dis. 5(e1187)2014.PubMed/NCBI View Article : Google Scholar
50	Zhou S, Zilberman Y, Wassermann K, Bain SD, Sadovsky Y and Gazit D: Estrogen modulates estrogen receptor alpha and beta expression, osteogenic activity, and apoptosis in mesenchymal stem cells (MSCs) of osteoporotic mice. J Cell Biochem Suppl. 36:144–155. 2001.PubMed/NCBI View Article : Google Scholar
51	Yang N, Wang G, Hu C, Shi Y, Liao L, Shi S, Cai Y, Cheng S, Wang X, Liu Y, et al: Tumor necrosis factor alpha suppresses the mesenchymal stem cell osteogenesis promoter miR-21 in estrogen deficiency-induced osteoporosis. J Bone Miner Res. 28:559–573. 2013.PubMed/NCBI View Article : Google Scholar
52	Sang C, Zhang Y, Chen F, Huang P, Qi J, Wang P, Zhou Q, Kang H, Cao X and Guo L: Tumor necrosis factor alpha suppresses osteogenic differentiation of MSCs by inhibiting semaphorin 3B via Wnt/β-catenin signaling in estrogen-deficiency induced osteoporosis. Bone. 84:78–87. 2016.PubMed/NCBI View Article : Google Scholar

Journals